Andrew Paul
CEO & Founder @ Sopris Capital Associates
Andrew Paul is a Series A investor at Sopris Capital Associates focused on Finance and mHealth. Andy Paul is the managing member and a founding member of Sopris Capital.Mr. Paul has been actively engaged in private equity and venture capital investing for more than 30 years, primarily in the healthcare industry. In 1984, he joined Welsh Carson Anderson & Stowe (1984-2000), a private investment firm that specializes in venturecapital/LBO opportunities, after working for the venture capital group of Hambrecht & Quist as an Associate (1983-1984). Since its founding in 1979, Welsh Carson has become one of the oldest, largest and most successful private equity investment firms in the U.S. focusing exclusively on information services, communications, and healthcare. During his 16 year tenure at Welsh Carson, he was jointly responsible for healthcare investing and was one of two lead partners for 38 investments in the healthcare industry, serving on the board of directors of 11 companies that successfully completed public offerings. At the time he left the firm in 2000, he had held a position on the Management Committee as a senior executive of the firm, and the firm had grown to an aggregate capital base of approximately $12 billion, which was an 84 times increase in capital over Mr. Paul’s tenure with the firm. Mr. Paul retired from Welsh Carson in September 2000 to focus his time on his other investment interests including Sopris Capital.Andy Paul is the Founder and Chairman of Enhanced Capital Partners (ECP), a state-sponsored small business investment vehicle formed in 1999 to provide capital to small and emerging companies in specified geographies. Since its founding, ECP has raised $450 million of capital. He is also the co-founder and managing partner of Enhanced Healthcare Partners, a $600 million equity fund focused on buyouts and growth capital investments in lower middle-market companies in the healthcare industry.Andy received his B.A. from Cornell University in 1978 and his MBA from Harvard Business School in 1983. He is a Trustee of the Cancer Research Institute and a Trustee Emeritus of Cornell University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Andrew Paul invests in
Stages Andrew Paul invests in
Countries Andrew Paul invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Finance 1 (33%)
- mHealth 1 (33%)
- E-Commerce 1 (33%)
- Health Care 1 (33%)
- Employee Benefits 1 (33%)
Stage
- Series A 2 (67%)
- Post-IPO Equity 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bitcoin Depot
|
Bitcoin Depot is an INC 5000 company, that stands as the fastest-growing multi-cryptocurrency ATM Network. The company specialises in seamless transactions, it empowers users with the capability to effortlessly buy and sell various cryptocurrencies. The company's exponential growth solidifies its position in the evolving cryptocurrencylandscape. | Post-IPO Equity / Apr 25, 2024 | |
DeLorean Artificial Intelligence
|
DeLorean AI is an artificial intelligence product company with products in healthcare (Medical AI) & sales (Sales AI). Medical AI predicts disease onset, transition and next best action (NBA) to slow the progress of disease and get the patient better. Medical AI is the first AI in the world to be biologically validated as well as the first AIto be applied at scale to focus on patient health. Currently, Medical AI has processed 45M patients and touches ~50% of the renal patients in the USA. Medical AI on average saves $100PMPM. Sales AI has been developed for B2B and B2C and is deployed at Fortune 500 companies.Our business model is AI as a Service. | $7.5M / Series A / Aug 01, 2023 | |
Wellnecity
|
Wellnecity is a healthcare technology solutions innovator that’s reinventing the way employers and employees interact with healthcare. Their innovative approach to healthcare benefits delivery delivers financial savings, improved population health, and better individual health for US employers and their employees. They are leveraging technologyto improve both the quality of data and the access that’s necessary to improve healthcare purchase and usage decisions. Their competitive advantage is our actionable data, which creates significant value for clients. | $3.2M / Series A / Jan 11, 2022 |
Co-Investors
Sopris Capital is a venture capital investment firm focused on providing growth capital to exceptional technology-enabled service and healthcare businesses.
Sopris Capital Associates Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Abinav Sankar
Partner
|
|||
Andrew Miller
Controller
|
|||
|
Andrew Paul
CEO & Founder
|
|||
Jason Smith
Partner - Private Equity
|
|||
Mark Groner
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andrew Paul invest in?
Andrew Paul invests primarily in Finance, mHealth and E-Commerce startups, most often at Series A and Post-IPO Equity stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Andrew Paul?
Public channels for Andrew Paul include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Andrew Paul last invest?
The most recent investment recorded for Andrew Paul closed in Apr 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
